Today's Times references an article in the Telegraph saying IRE / nanoknife is being offered on the NHS at UCLH. Here's an extract..
'...Men with prostate cancer have been treated for the first time on the NHS with a minimally invasive technique which uses electrical pulses to kill cancerous cells.
The treatment can tackle tumours which are hard to reach, has few side effects and does not require an overnight stay, helping reduce pressure on hospital beds.....
.. .The University College London Hospitals NHS Foundation Trust (UCLH) has now used the technique on six prostate cancer patients.
The technique works by administering quick electrical pulses around the tumour to kill the cancerous cells by using electrodes.
Guided by MRI scanning, the pulses can be targeted to exactly the right area, posing fewer risks. The pulses are short and do not generate any heat, leaving the surrounding healthy cells untouched.
The pulses effectively cut open the cell’s membrane, inducing apoptosis, a process of programmed cell death...
....One of the first patients treated at UCLH was Neil Gershon, 70, who had the procedure in early November said: “What appealed to me about the electroporation treatment was that it was minimally invasive and very precise, also that the likelihood of side effects was very low compared to other treatments.
“It was all done in a day which was great. When the general anaesthetic wore off, I felt absolutely fine, no pain at all. It couldn’t have gone better.
The treatment requires the patient to wear a catheter for a few days after completion and Gershon had the catheter removed at his local hospital one week later....
Professor Mark Emberton, a consultant urologist at UCLH, told the Daily Telegraph that the technique was a “game changer”, partly because it was simple to train surgeons to use it.
He said that very few men were currently offered focal therapies, which include irreversible electroporation, the freezing technique cryotherapy and focused ultrasound.
“At the moment you can only get focal therapies in a few centres in the south of England — which is terrible,” Emberton said
“Around a third of men with prostate cancer could benefit from some type of focal therapy but only a tiny fraction of them even get a discussion about it.”
Emberton said that he hoped to see a rapid uptake of the treatment at hospitals across the country.
“It’s an amazing treatment — so quick. And it means we can reach tumours that are beyond where the knife can reach,” he said.
Natalia Norori, knowledge manager at Prostate Cancer UK, said: “Early studies suggest that treatments like Nanoknife could effectively treat prostate cancer while also reducing side effects for men.'
Edited by member 03 Jan 2022 at 20:49
| Reason: Not specified